396 filings
Page 4 of 20
8-K
ykczde03w ck0
27 Aug 21
Completion of Acquisition or Disposition of Assets
8:47am
425
vpdy 11zisw
12 Aug 21
Business combination disclosure
11:00am
8-K
i6r85dhf3p4q5b
12 Aug 21
Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2022
10:57am
425
6a7j7 lutxd
4 Aug 21
Business combination disclosure
5:03pm
425
tdorl
4 Aug 21
Business combination disclosure
5:00pm
8-K
ijhwy
23 Jul 21
Other Events
8:43am
425
ypk38xzo
23 Jul 21
Business combination disclosure
8:41am
8-K
7fuogp4e
21 Jul 21
Other Events
5:17pm
425
psrvb3i x6
21 Jul 21
Business combination disclosure
5:15pm
EFFECT
kf4c3aeoa d9kh10k
16 Jul 21
Notice of effectiveness
12:15am
424B3
c2vg tg0d
15 Jul 21
Prospectus supplement
4:45pm
S-4/A
aygmwmhquuqgsf3ec
13 Jul 21
Registration of securities issued in business combination transactions (amended)
4:41pm
CORRESP
1out19nkkcdgl8g u0v
13 Jul 21
Correspondence with SEC
12:00am
UPLOAD
lsx3qafhkay7iez4
6 Jul 21
Letter from SEC
12:00am
S-4
59ea3i8r ddm7wz
1 Jul 21
Registration of securities issued in business combination transactions
12:00am
8-K
5bgbxvt34
22 Jun 21
Acasti Pharma Provides Fiscal 2021 Year-End Business Update
7:00am
8-K
jf4r nmio
17 May 21
Acasti Intends to Request Hearing Before Nasdaq Panel to Present Plan of Compliance
7:11am
8-K
02w8zcx79176 7k5n
7 May 21
Entry into a Material Definitive Agreement
7:09am